Health

COVID-19 Impact Analysis on Sjogren’s Syndrome Therapeutics Market | 3.68% YOY growth expected in 2021 | Technavio

NEW YORK, May 10, 2021 /PRNewswire/ —

Technavio has announced its latest market research report titled Sjogrens Syndrome Therapeutics Market by Type and Geography - Forecast and Analysis 2021-2025

The Sjogren’s syndrome therapeutics market is poised to grow by USD 287.68 million during 2021-2025, progressing at a CAGR of about 4% during the forecast period.

Our report talks about market scenarios, estimates, the impact of lockdown, and customer behavior.

Get FREE Sample Report in Minutes!

The report on the Sjogren’s syndrome therapeutics market provides a holistic update, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis.

The report offers an up-to-date analysis regarding the current global market scenario and the overall market environment. The market is driven by the presence of a strong drug pipeline.

The Sjogren’s syndrome therapeutics market analysis includes the type segment and geographic landscape. This study identifies the Initiatives and expected approvals of products as one of the prime reasons driving the Sjogren’s syndrome therapeutics market growth during the next few years.

This report presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters.

The Sjogren’s syndrome therapeutics market covers the following areas:

Sjogren’s Syndrome Therapeutics Market Sizing

Sjogren’s Syndrome Therapeutics Market Forecast

Sjogren’s Syndrome Therapeutics Market Analysis

More details: www.technavio.com/talk-to-us?report=IRTNTR70328

Companies Mentioned

  • AbbVie Inc.
  • ADVANZ PHARMA Corp. Ltd.
  • Biogen Inc.
  • Bristol-Myers Squibb Co.
  • Daiichi Sankyo Co. Ltd.
  • Hikma Pharmaceuticals Plc
  • Johnson & Johnson
  • Novartis AG
  • Sanofi SA
  • Sun Pharmaceutical Industries Ltd.

Related Reports on Healthcare Include:

Global Dravet Syndrome Treatment Market – Global Dravet syndrome treatment market is segmented by Product (SGDs, TGDs, and FGDs) and Geography (North America, Europe, Asia, and ROW).

Download Exclusive Free Sample Report

Global Dry Eye Syndrome Drugs Market – Global dry eye syndrome market is segmented by product (OTC drugs and prescription drugs) and geography (Asia, Europe, North America, and ROW).

Download Exclusive Free Sample Report


Key Topics Covered:

Executive Summary

Market Landscape

  • Market ecosystem
  • Value chain analysis

Market Sizing

  • Market definition
  • Market segment analysis
  • Market size 2020
  • Market outlook: Forecast for 2020 – 2025

Five Forces Analysis

  • Five forces summary
  • Bargaining power of buyers
  • Bargaining power of suppliers
  • Threat of new entrants
  • Threat of substitutes
  • Threat of rivalry
  • Market condition

Market Segmentation by Type

  • Market segments
  • Comparison by Type
  • Primary Sjogren’s syndrome – Market size and forecast 2020-2025
  • Secondary Sjogren’s syndrome – Market size and forecast 2020-2025
  • Market opportunity by Type

Customer Landscape

Geographic Landscape

  • Geographic segmentation
  • Geographic comparison
  • North America – Market size and forecast 2020-2025
  • Europe – Market size and forecast 2020-2025
  • Asia – Market size and forecast 2020-2025
  • ROW – Market size and forecast 2020-2025
  • Key leading countries
  • Market opportunity by geography
  • Market drivers
  • Market challenges
  • Market trends

Vendor Landscape

  • Overview
  • Vendor landscape
  • Landscape disruption

Vendor Analysis

  • Vendors covered
  • Market positioning of vendors
  • AbbVie Inc.
  • ADVANZ PHARMA Corp. Ltd.
  • Biogen Inc.
  • Bristol-Myers Squibb Co.
  • Daiichi Sankyo Co. Ltd.
  • Hikma Pharmaceuticals Plc
  • Johnson & Johnson
  • Novartis AG
  • Sanofi SA
  • Sun Pharmaceutical Industries Ltd.

Appendix

  • Scope of the report
  • Currency conversion rates for US$
  • Research methodology
  • List of abbreviations

Technavio suggests three forecast scenarios (optimistic, probable, and pessimistic) considering the impact of COVID-19. Technavio’s in-depth research has direct and indirect COVID-19 impacted market research reports.

Register for a free trial today and gain instant access to 17,000+ market research reports. 

Technavio’s SUBSCRIPTION platform

About Us

Technavio is a leading global technology research and advisory company. Their research and analysis focuses on emerging market trends and provides actionable insights to help businesses identify market opportunities and develop effective strategies to optimize their market positions. With over 500 specialized analysts, Technavio’s report library consists of more than 17,000 reports and counting, covering 800 technologies, spanning across 50 countries. Their client base consists of enterprises of all sizes, including more than 100 Fortune 500 companies. This growing client base relies on Technavio’s comprehensive coverage, extensive research, and actionable market insights to identify opportunities in existing and potential markets and assess their competitive positions within changing market scenarios.



Contact

Technavio Research

Jesse Maida

Media & Marketing Executive

US: +1 844 364 1100

UK: +44 203 893 3200

Email: media@technavio.com

Website: www.technavio.com/

Report: www.technavio.com/report/sjogren-s-syndrome-therapeutics-market-industry-analysis

Cision View original content to download multimedia:http://www.prnewswire.com/news-releases/covid-19-impact-analysis-on-sjogrens-syndrome-therapeutics-market–3-68-yoy-growth-expected-in-2021–technavio-301286466.html

SOURCE Technavio

Related Posts

1 of 851